Finanzwire Finanzwire
Basculer en Français
10184 Companies
209559 Keywords
139677 Articles
111093 Press releases
Headlines Articles Press releases Quantum Genomics Remove
  1. Home
  2. Companies
  3. Quantum Genomics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 09/04/2024 at 18:00, 1 year 7 months ago

    Quantum Genomics reviewed its financial situation and announced that it has filed a declaration of cessation of payment today

    Quantum Genomics files declaration of cessation of payments with Paris Commercial Court after failed fundraising negotiations, impacting subsidiary Exactcure
    Financial Situation Cessation Of Payments Quantum Genomics ExactCure Judicial Winding-up
    Logo of Quantum Genomics
  • BRIEF

    published on 04/25/2024 at 08:05, 1 year 11 months ago

    Quantum Genomics approves strategic tie-up with ExactCure

    Capital Reduction General Assembly HealthTech Quantum Genomics ExactCure
  • PRESS RELEASE

    published on 04/25/2024 at 08:00, 1 year 11 months ago

    Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.

    Quantum Genomics successfully approved transactions of reducing share capital and acquiring Exactcure's shares during Shareholders' General Meeting. Company now holds 100% of Exactcure, reinforcing market position
    Shareholders Share Capital Quantum Genomics ExactCure Merger Project
    Logo of Quantum Genomics
Previous page
1 2
Accesswire
  • Published on 04/09/2026 at 16:00, 2 hours 38 minutes ago

    Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X

  • Published on 04/09/2026 at 14:40, 3 hours 58 minutes ago

    Silver X Delivers Production Growth During the First Quarter of 2026

  • Published on 04/09/2026 at 14:00, 4 hours 38 minutes ago

    Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

  • Published on 04/09/2026 at 13:30, 5 hours 8 minutes ago

    Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

  • Published on 04/09/2026 at 13:30, 5 hours 8 minutes ago

    ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE
EQS Group
  • Published on 04/09/2026 at 18:15, 23 minutes ago

    REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares

  • Published on 04/09/2026 at 15:59, 2 hours 39 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:57, 2 hours 41 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 04/09/2026 at 15:40, 2 hours 58 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 04/09/2026 at 15:39, 2 hours 59 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS
Les Echos
  • Published on 04/09/2026 at 18:35, 3 minutes ago

    Availability of proxy documents for the Combined General Meeting of April 30, 2026

  • Published on 04/09/2026 at 17:35, 1 hour 3 minutes ago

    SUEZ - FY 2025

  • Published on 04/09/2026 at 15:57, 2 hours 41 minutes ago

    Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports

  • Published on 04/09/2026 at 07:00, 11 hours 38 minutes ago

    bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

  • Published on 04/08/2026 at 18:02, 1 day ago

    Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy